Annual report
9265.TEDINET S100RQBX
Period2022-06-01 → 2023-05-31
Filed2023-08-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥58.2bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales |
| Revenue | ¥55.1bn | 2021-06-01 → 2022-05-31 | Cons. | Net sales |
| Revenue | ¥70.1bn | 2020-06-01 → 2021-05-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥64.7bn | 2019-06-01 → 2020-05-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥61.5bn | 2018-06-01 → 2019-05-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.2bn | 2022-06-01 → 2023-05-31 | Cons. | Operating income |
| Operating income | ¥930m | 2021-06-01 → 2022-05-31 | Cons. | Operating income |
| Ordinary income | ¥1.2bn | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2021-06-01 → 2022-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2020-06-01 → 2021-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥642m | 2019-06-01 → 2020-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥617m | 2018-06-01 → 2019-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥635m | 2022-06-01 → 2023-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.0bn | 2021-06-01 → 2022-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥219m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥696m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥678m | 2020-06-01 → 2021-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥459m | 2019-06-01 → 2020-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥144m | 2018-06-01 → 2019-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥211m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss |
| Net income | ¥695m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss |
| Total assets | ¥24.6bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥24.1bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥24.3bn | at 2021-05-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥21.4bn | at 2020-05-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥20.3bn | at 2019-05-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥16.6bn | at 2023-05-31 | Cons. | Liabilities |
| Total liabilities | ¥16.1bn | at 2022-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.9bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥8.0bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥7.6bn | at 2021-05-31d | Cons. | Net assets |
| Net assets / equity | ¥6.9bn | at 2020-05-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥6.4bn | at 2019-05-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.8bn | at 2023-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.0bn | at 2022-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.8bn | at 2023-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.0bn | at 2022-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.7bn | at 2021-05-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.0bn | at 2020-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.3bn | at 2019-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.2bn | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥581m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥911m | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥817m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥101m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥107m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥27m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥134m | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥33m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥49m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥209m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥229m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥137m | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥107m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥366m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥85.83 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥272.67 | 2021-06-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥265.77 | 2020-06-01 → 2021-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥180.07 | 2019-06-01 → 2020-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.57 | 2018-06-01 → 2019-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥3,097.34 | at 2023-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,126.18 | at 2022-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,969.03 | at 2021-05-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,717.81 | at 2020-05-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,496.1 | at 2019-05-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 32.2% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.2% | at 2021-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.4% | at 2020-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.4% | at 2019-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 2.8% | 2022-06-01 → 2023-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.9% | 2021-06-01 → 2022-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.3% | 2020-06-01 → 2021-05-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2019-06-01 → 2020-05-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.3% | 2018-06-01 → 2019-05-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 570 | at 2023-05-31 | Cons. | Number of employees |
| Employees | 574 | at 2022-05-31 | Cons. | Number of employees |
| Employees | 553 | at 2021-05-31d | Cons. | Number of employees |
| Employees | 551 | at 2020-05-31d | Cons. | Number of employees |
| Employees | 552 | at 2019-05-31d | Cons. | Number of employees |
| Revenue | ¥498m | 2022-06-01 → 2023-05-31 | Standalone | Operating revenue1 |
| Revenue | ¥792m | 2021-06-01 → 2022-05-31 | Standalone | Operating revenue1 |
| Revenue | ¥854m | 2020-06-01 → 2021-05-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥508m | 2019-06-01 → 2020-05-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥448m | 2018-06-01 → 2019-05-31d | Standalone | Operating revenue1 (5-year summary) |
| Operating income | −¥16m | 2022-06-01 → 2023-05-31 | Standalone | Operating income |
| Operating income | ¥227m | 2021-06-01 → 2022-05-31 | Standalone | Operating income |
| Ordinary income | −¥16m | 2022-06-01 → 2023-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥227m | 2021-06-01 → 2022-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥347m | 2020-06-01 → 2021-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥136m | 2019-06-01 → 2020-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥128m | 2018-06-01 → 2019-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥16m | 2022-06-01 → 2023-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥227m | 2021-06-01 → 2022-05-31 | Standalone | Income before income taxes |
| Net income | −¥13m | 2022-06-01 → 2023-05-31 | Standalone | Profit loss |
| Net income | ¥228m | 2021-06-01 → 2022-05-31 | Standalone | Profit loss |
| Net income | ¥348m | 2020-06-01 → 2021-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥100m | 2019-06-01 → 2020-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥124m | 2018-06-01 → 2019-05-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥6.3bn | at 2023-05-31 | Standalone | Assets |
| Total assets | ¥6.5bn | at 2022-05-31 | Standalone | Assets |
| Total assets | ¥6.4bn | at 2021-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥6.0bn | at 2020-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥5.9bn | at 2019-05-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥489m | at 2023-05-31 | Standalone | Liabilities |
| Total liabilities | ¥498m | at 2022-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥5.8bn | at 2023-05-31 | Standalone | Net assets |
| Net assets / equity | ¥6.0bn | at 2022-05-31 | Standalone | Net assets |
| Net assets / equity | ¥6.0bn | at 2021-05-31d | Standalone | Net assets |
| Net assets / equity | ¥5.8bn | at 2020-05-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥5.8bn | at 2019-05-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥175m | at 2023-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥229m | at 2022-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-5.29 | 2022-06-01 → 2023-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥89.32 | 2021-06-01 → 2022-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥136.46 | 2020-06-01 → 2021-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.38 | 2019-06-01 → 2020-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.96 | 2018-06-01 → 2019-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥48 | 2022-06-01 → 2023-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥82 | 2021-06-01 → 2022-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥90 | 2020-06-01 → 2021-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥54 | 2019-06-01 → 2020-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥42 | 2018-06-01 → 2019-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,272.88 | at 2023-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,360.07 | at 2022-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,360.75 | at 2021-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,278.24 | at 2020-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,280.98 | at 2019-05-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 92.2% | at 2023-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.4% | at 2022-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.8% | at 2021-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 96.9% | at 2020-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.2% | at 2019-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | -0.2% | 2022-06-01 → 2023-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.8% | 2021-06-01 → 2022-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.9% | 2020-06-01 → 2021-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.7% | 2019-06-01 → 2020-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.2% | 2018-06-01 → 2019-05-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,553,000 | at 2023-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,553,000 | at 2022-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,553,000 | at 2021-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,553,000 | at 2020-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,553,000 | at 2019-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 30 | at 2023-05-31 | Standalone | Number of employees |
| Employees | 27 | at 2022-05-31 | Standalone | Number of employees |
| Employees | 24 | at 2021-05-31d | Standalone | Number of employees |
| Employees | 20 | at 2020-05-31d | Standalone | Number of employees |
| Employees | 19 | at 2019-05-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2022-06-01 → 2023-05-31 | ¥31m |
| Reconciling Itemsreconciling | revenue | 2022-06-01 → 2023-05-31 | −¥12m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-06-01 → 2023-05-31 | −¥12m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2023-05-31 | −¥1.0bn |
| Medical Equipment Manufacturing And Salesreportable segment | depreciation | 2022-06-01 → 2023-05-31 | ¥4m |
| Medical Equipment Manufacturing And Salesreportable segment | employees | at 2023-05-31 | 5 pure |
| Medical Equipment Manufacturing And Salesreportable segment | revenue | 2022-06-01 → 2023-05-31 | ¥286m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2022-06-01 → 2023-05-31 | ¥286m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2022-06-01 → 2023-05-31 | ¥0 |
| Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2022-06-01 → 2023-05-31 | ¥12m |
| Medical Equipment Salesreportable segment | depreciation | 2022-06-01 → 2023-05-31 | ¥137m |
| Medical Equipment Salesreportable segment | employees | at 2023-05-31 | 522 pure |
| Medical Equipment Salesreportable segment | revenue | 2022-06-01 → 2023-05-31 | ¥57.9bn |
| Medical Equipment Salesreportable segment | revenue external | 2022-06-01 → 2023-05-31 | ¥57.8bn |
| Medical Equipment Salesreportable segment | revenue intersegment | 2022-06-01 → 2023-05-31 | ¥11m |
| Medical Equipment Salesreportable segment | segment profit | 2022-06-01 → 2023-05-31 | ¥2.1bn |
| Medical Mallreportable segment | depreciation | 2022-06-01 → 2023-05-31 | ¥16m |
| Medical Mallreportable segment | revenue | 2022-06-01 → 2023-05-31 | ¥69m |
| Medical Mallreportable segment | revenue external | 2022-06-01 → 2023-05-31 | ¥69m |
| Medical Mallreportable segment | segment profit | 2022-06-01 → 2023-05-31 | ¥0 |
| —segment total | depreciation | 2022-06-01 → 2023-05-31 | ¥157m |
| —segment total | revenue | 2022-06-01 → 2023-05-31 | ¥58.2bn |
| —segment total | revenue external | 2022-06-01 → 2023-05-31 | ¥58.2bn |
| —segment total | revenue intersegment | 2022-06-01 → 2023-05-31 | ¥12m |
| —segment total | segment profit | 2022-06-01 → 2023-05-31 | ¥2.2bn |
| Reconciling Itemsreconciling | depreciation | 2021-06-01 → 2022-05-31 | ¥35m |
| Reconciling Itemsreconciling | revenue | 2021-06-01 → 2022-05-31 | −¥6m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-06-01 → 2022-05-31 | −¥6m |
| Reconciling Itemsreconciling | segment profit | 2021-06-01 → 2022-05-31 | −¥1.0bn |
| Medical Equipment Manufacturing And Salesreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥6m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥287m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥287m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥0 |
| Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥20m |
| Medical Equipment Salesreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥142m |
| Medical Equipment Salesreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥54.8bn |
| Medical Equipment Salesreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥54.8bn |
| Medical Equipment Salesreportable segment | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥5m |
| Medical Equipment Salesreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥2.0bn |
| Medical Mallreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥14m |
| Medical Mallreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥68m |
| Medical Mallreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥68m |
| Medical Mallreportable segment | segment profit | 2021-06-01 → 2022-05-31 | −¥46m |
| —segment total | depreciation | 2021-06-01 → 2022-05-31 | ¥163m |
| —segment total | revenue | 2021-06-01 → 2022-05-31 | ¥55.2bn |
| —segment total | revenue external | 2021-06-01 → 2022-05-31 | ¥55.1bn |
| —segment total | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥6m |
| —segment total | segment profit | 2021-06-01 → 2022-05-31 | ¥1.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,346
| Item | Context | Value | Unit |
|---|---|---|---|
| Other noi | Prior1YearDuration | 23000000 | JPY |
| Other noi | CurrentYearDuration | 19000000 | JPY |
| Non operating income | Prior1YearDuration | 86000000 | JPY |
| Non operating income | CurrentYearDuration | 71000000 | JPY |
| Interest expenses noe | Prior1YearDuration | 3000000 | JPY |
| Interest expenses noe | CurrentYearDuration | 2000000 | JPY |
| Equity in losses of affiliates noe | Prior1YearDuration | － | JPY |
| Equity in losses of affiliates noe | CurrentYearDuration | 7000000 | JPY |
| Loss on sales of notes payable noe | Prior1YearDuration | 5000000 | JPY |
| Loss on sales of notes payable noe | CurrentYearDuration | 7000000 | JPY |
| Foreign exchange losses noe | Prior1YearDuration | 1000000 | JPY |
| Foreign exchange losses noe | CurrentYearDuration | － | JPY |
| Other noe | Prior1YearDuration | 2000000 | JPY |
| Other noe | CurrentYearDuration | 3000000 | JPY |
| Non operating expenses | Prior1YearDuration | 12000000 | JPY |
| Non operating expenses | CurrentYearDuration | 20000000 | JPY |
| Ordinary income | Prior1YearDuration | 1003000000 | JPY |
| Ordinary income | CurrentYearDuration | 1206000000 | JPY |
| Receipts from contingent consideration ei | Prior1YearDuration | 17000000 | JPY |
| Receipts from contingent consideration ei | CurrentYearDuration | 6000000 | JPY |
| Gain on step acquisitions ei | Prior1YearDuration | 4000000 | JPY |
| Gain on step acquisitions ei | CurrentYearDuration | － | JPY |
| Gain on sales of investment securities ei | Prior1YearDuration | － | JPY |
| Gain on sales of investment securities ei | CurrentYearDuration | 33000000 | JPY |
| Extraordinary income | Prior1YearDuration | 21000000 | JPY |
| Extraordinary income | CurrentYearDuration | 39000000 | JPY |
| Provision of allowance for doubtful accounts el | Prior1YearDuration | － | JPY |
| Provision of allowance for doubtful accounts el | CurrentYearDuration | 611000000 | JPY |
| Extraordinary loss | Prior1YearDuration | － | JPY |
| Extraordinary loss | CurrentYearDuration | 611000000 | JPY |
| Income before income taxes | Prior1YearDuration | 1025000000 | JPY |
| Income before income taxes | CurrentYearDuration | 635000000 | JPY |
| Income taxes current | Prior1YearDuration | 285000000 | JPY |
| Income taxes current | CurrentYearDuration | 442000000 | JPY |
| Income taxes deferred | Prior1YearDuration | 44000000 | JPY |
| Income taxes deferred | CurrentYearDuration | -18000000 | JPY |
| Income taxes | Prior1YearDuration | 330000000 | JPY |
| Income taxes | CurrentYearDuration | 423000000 | JPY |
| Profit loss | Prior1YearDuration | 695000000 | JPY |
| Profit loss | CurrentYearDuration | 211000000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YearDuration | -0 | JPY |
| Profit loss attributable to non controlling interests | CurrentYearDuration | -7000000 | JPY |
| Profit loss attributable to owners of parent | Prior1YearDuration | 696000000 | JPY |
| Profit loss attributable to owners of parent | CurrentYearDuration | 219000000 | JPY |
| Profit loss | Prior1YearDuration | 695000000 | JPY |
| Profit loss | CurrentYearDuration | 211000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YearDuration | 1000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYearDuration | -87000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YearDuration | -66000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYearDuration | 4000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |